GO:0016323; C:basolateral plasma membrane; IDA:BHF-UCL
GO:0009986; C:cell surface; IDA:BHF-UCL
GO:0031410; C:cytoplasmic vesicle; IDA:BHF-UCL
GO:0005615; C:extracellular space; IDA:BHF-UCL
GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW
GO:0005634; C:nucleus; IEA:Ensembl
GO:0048471; C:perinuclear region of cytoplasm; IDA:BHF-UCL
GO:0005886; C:plasma membrane; NAS:ProtInc
GO:0005154; F:epidermal growth factor receptor binding; IDA:UniProtKB
GO:0008083; F:growth factor activity; IDA:HGNC
GO:0004708; F:MAP kinase kinase activity; IDA:HGNC
GO:0000187; P:activation of MAPK activity; IDA:HGNC
GO:0001525; P:angiogenesis; IEA:Ensembl
GO:0008283; P:cell proliferation; TAS:ProtInc
GO:0007173; P:epidermal growth factor receptor signaling pathway; IEA:Ensembl
GO:0060749; P:mammary gland alveolus development; IEA:Ensembl
GO:0000165; P:MAPK cascade; IDA:GOC
GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
GO:0045741; P:positive regulation of epidermal growth factor-activated receptor activity; IDA:HGNC
GO:0050679; P:positive regulation of epithelial cell proliferation; IDA:HGNC
GO:0045840; P:positive regulation of mitosis; IDA:HGNC
GO:0042493; P:response to drug; IEA:Ensembl
GO:0042060; P:wound healing; IEA:Ensembl